BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$4.89B |
| 2 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$2.11B |
| 3 |
Cigna
CI
|
+$2.09B |
| 4 |
ExxonMobil
XOM
|
+$1.33B |
| 5 |
Verizon
VZ
|
+$1.32B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$4.73B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$3.38B |
| 3 |
PX
Praxair Inc
PX
|
+$2.8B |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$2.28B |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.96% |
| 2 | Healthcare | 14.79% |
| 3 | Financials | 14.43% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Industrials | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIZP
2526
DELISTED
Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value
AIZP
| $29M | ﹤0.01% |
295,762
-35,807
| -11% | -$3.78M |
|
|
LKFT
2527
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
| $29M | ﹤0.01% |
316,323
-49,090
| -13% | -$4.98M |
|
2528
Inovio Pharmaceuticals
INO
$76.1M
| $29M | ﹤0.01% |
604,327
+24,382
| +4% | +$1.48M |
|
2529
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $29M | ﹤0.01% |
839,356
+834,832
| +18,453% | +$31.3M |
|
|
TAST
2530
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $29M | ﹤0.01% |
2,942,825
-336,304
| -10% | -$4.02M |
|
2531
Lexicon Pharmaceuticals
LXRX
$1.07B
| $28.9M | ﹤0.01% |
4,356,726
-50,915
| -1% | -$412K |
|
|
GRFS
2532
Grifois
GRFS
$5.48B
| $28.8M | ﹤0.01% |
1,571,263
-67,834
| -4% | -$1.35M |
|
2533
iShares MSCI Brazil ETF
EWZ
$8.91B
| $28.8M | ﹤0.01% |
754,041
+316,374
| +72% | +$12.3M |
|
|
NEX
2534
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $28.8M | ﹤0.01% |
3,520,538
-86,396
| -2% | -$964K |
|
|
CAI
2535
DELISTED
CAI International, Inc.
CAI
| $28.8M | ﹤0.01% |
1,239,028
+21,376
| +2% | +$486K |
|
2536
Rocket Pharmaceuticals
RCKT
$397M
| $28.7M | ﹤0.01% |
1,938,560
+470,451
| +32% | +$7.81M |
|
|
CBLK
2537
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $28.7M | ﹤0.01% |
2,139,396
+1,513,617
| +242% | +$24.9M |
|
2538
ADT
ADT
$5.49B
| $28.6M | ﹤0.01% |
4,765,773
-387,742
| -8% | -$2.92M |
|
|
GLDD
2539
DELISTED
Great Lakes Dredge & Dock
GLDD
| $28.3M | ﹤0.01% |
4,280,035
+303,406
| +8% | +$1.98M |
|
2540
Vera Bradley
VRA
$96.4M
| $28.3M | ﹤0.01% |
3,303,722
+52,306
| +2% | +$614K |
|
|
NIHD
2541
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $28.3M | ﹤0.01% |
6,412,748
+228,987
| +4% | +$1.27M |
|
2542
Accuray
ARAY
$34.9M
| $28.3M | ﹤0.01% |
8,292,581
-239,262
| -3% | -$970K |
|
2543
iShares Global REIT ETF
REET
$5.04B
| $28.3M | ﹤0.01% |
1,207,368
+40,063
| +3% | +$986K |
|
|
FPRX
2544
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $28.3M | ﹤0.01% |
3,039,915
+127,777
| +4% | +$1.52M |
|
2545
Equity Bancshares
EQBK
$1.04B
| $28.3M | ﹤0.01% |
801,575
+35,604
| +5% | +$1.3M |
|
|
DBD
2546
DELISTED
Diebold Nixdorf Incorporated
DBD
| $28.2M | ﹤0.01% |
11,339,245
+345,399
| +3% | +$1.24M |
|
2547
Expro Ltd
XPRO
$2.01B
| $28.1M | ﹤0.01% |
896,743
+3,707
| +0.4% | +$161K |
|
2548
iShares Investment Grade Systematic Bond ETF
IGEB
$1.51B
| $28.1M | ﹤0.01% |
592,400
+21,070
| +4% | +$995K |
|
2549
Bilibili
BILI
$7.95B
| $28M | ﹤0.01% |
1,921,432
+458,999
| +31% | +$6.43M |
|
|
EQM
2550
DELISTED
EQM Midstream Partners, LP
EQM
| $28M | ﹤0.01% |
647,249
+114,885
| +22% | +$5.48M |
|
Similar funds
BlackRock's Q4 2018 Portfolio in Review
As of Q4 2018, BlackRock held 5,211 positions worth $1.98T, down 14% from $2.31T the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock's Q4 2018 filing shows 169 new, 3,017 increased, 1,308 reduced and 195 closed positions. Its largest new stake was Linde: 30,937,347 shares worth $4.83B. The largest sale was Aetna Inc, an estimated $4.73B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q4 2018 buy was Linde: 30,937,347 shares worth $4.83B.
- BlackRock added most to iShares Core MSCI Total International Stock ETF in Q4 2018, an estimated $2.11B increase.
- BlackRock's biggest Q4 2018 reduction was iShares Russell 1000 ETF, cutting an estimated $2.28B.
- BlackRock fully exited Aetna Inc in Q4 2018, selling an estimated $4.73B.
- BlackRock's ten largest holdings make up 14% of its $1.98T portfolio in Q4 2018.
- BlackRock opened 169 new positions and closed 195 in Q4 2018.
- BlackRock's portfolio value fell 14% quarter-over-quarter to $1.98T.
Based on BlackRock's 13F filing for Q4 2018, filed 8 Feb 2019.